BIM
FURX

BlackRock Investment Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

BlackRock Investment Management’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-19,537
Closed -$2.07M – 4143
2014
Q2 		$2.07M Buy
19,537
+1,057
+6% +$104K ﹤0.01% 2053
2014
Q1 		$1.61M Sell
18,480
-46
-0.2% -$3.55K ﹤0.01% 2185
2013
Q4 		$778K Sell
18,526
-255
-1% -$10.5K ﹤0.01% 2688
2013
Q3 		$826K Buy
18,781
+678
+4% +$28.1K ﹤0.01% 2583
2013
Q2 		$617K Buy
+18,103
New +$635K ﹤0.01% 2714

BlackRock Investment Management's FURX Position: Q3 2014 in Review

BlackRock Investment Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 19,537 shares — an estimated $2.07M sold.

BlackRock Investment Management first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $2.07M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • BlackRock Investment Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • BlackRock Investment Management sold 19,537 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $2.07M.
  • BlackRock Investment Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • BlackRock Investment Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.07M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on BlackRock Investment Management's 13F filing for Q3 2014, filed 29 Oct 2014.